Angiodynamic Inc (NASDAQ: ANGO) kicked off on Tuesday, down -3.33% from the previous trading day, before settling in for the closing price of $9.31. Over the past 52 weeks, ANGO has traded in a range of $5.47-$13.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 2.66% over the last five years. While this was happening, its average annual earnings per share was recorded 34.06%. With a float of $38.73 million, this company’s outstanding shares have now reached $40.97 million.
The firm has a total of 748 workers. Let’s measure their productivity. In terms of profitability, gross margin is 53.45%, operating margin of -8.99%, and the pretax margin is -14.85%.
Angiodynamic Inc (ANGO) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Angiodynamic Inc is 4.63%, while institutional ownership is 81.68%. The most recent insider transaction that took place on Jan 16 ’25, was worth 49,979. In this transaction SVP Quality and Regulatory of this company sold 4,060 shares at a rate of $12.31, taking the stock ownership to the 41,817 shares. Before that another transaction happened on Jan 16 ’25, when Company’s Officer proposed sale 4,060 for $12.31, making the entire transaction worth $49,979.
Angiodynamic Inc (ANGO) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 34.06% per share during the next fiscal year.
Angiodynamic Inc (NASDAQ: ANGO) Trading Performance Indicators
Take a look at Angiodynamic Inc’s (ANGO) current performance indicators. Last quarter, stock had a quick ratio of 1.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.02, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.23 in one year’s time.
Technical Analysis of Angiodynamic Inc (ANGO)
Analysing the last 5-days average volume posted by the [Angiodynamic Inc, ANGO], we can find that recorded value of 1.24 million was better than the volume posted last year of 0.73 million. As of the previous 9 days, the stock’s Stochastic %D was 11.95%. Additionally, its Average True Range was 0.67.
During the past 100 days, Angiodynamic Inc’s (ANGO) raw stochastic average was set at 34.50%, which indicates a significant increase from 7.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 81.25% in the past 14 days, which was higher than the 79.59% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.08, while its 200-day Moving Average is $8.28. Now, the first resistance to watch is $9.61. This is followed by the second major resistance level at $10.21. The third major resistance level sits at $10.56. If the price goes on to break the first support level at $8.65, it is likely to go to the next support level at $8.30. Now, if the price goes above the second support level, the third support stands at $7.70.
Angiodynamic Inc (NASDAQ: ANGO) Key Stats
The company with the Market Capitalisation of 365.46 million has total of 40,607K Shares Outstanding. Its annual sales at the moment are 303,910 K in contrast with the sum of -184,350 K annual income. Company’s last quarter sales were recorded 72,000 K and last quarter income was -4,410 K.
